by Daniel X. Thomas
EP 2 139 494 B1 relates to pharmaceutical formulations containing dapaglifozin (Forxiga™) propylene glycol hydrate.
Brief outline of the case
The patent was opposed by 6 opponents and the OD revoked the patent.
The board set aside the OD’s decision as it had committed a SPV.
The proprietor requested a different apportionment of costs which was refused by the board.
by Daniel X. Thomas
The patent relates to a switchgear assembly for medium voltage having a short circuit unit.
Brief outline of the case
The opposition was rejected and the opponent appealed.
The OD decided that the priority was valid. As consequence a public prior use at the Hannover fair was not part of the prior art.